What is Telirite?
Established in 1995, Telirite has cultivated a reputation for excellence in high-precision manufacturing. The company maintains a rigorous quality framework, evidenced by its ISO 9001:2015 and ISO 13485:2016 certifications, which are essential for serving the highly regulated medical device and advanced technology sectors. By providing comprehensive services ranging from PCB assembly to intricate mechanical component fabrication, Telirite functions as a critical partner for firms seeking to accelerate time-to-market while adhering to stringent regulatory specifications. Their market position is defined by a commitment to deep customer integration and technical reliability.
The company's ability to navigate complex manufacturing requirements has allowed it to remain a preferred vendor for clients requiring high-fidelity production standards. As the industry shifts toward more localized and resilient supply chains, Telirite's established infrastructure provides a significant competitive advantage in the current industrial landscape.
How much funding has Telirite raised?
Telirite has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Telirite
PPP
Public-Private Partnership
What's next for Telirite?
With this recent capital injection, Telirite is positioned to scale its manufacturing capabilities and further integrate advanced automation into its production lines. The strategic focus will likely center on enhancing throughput for medical device clients and expanding capacity for high-tech hardware assembly. By leveraging this late-stage financing, the company aims to solidify its market leadership, potentially exploring new geographic markets or investing in next-generation manufacturing technologies to maintain its competitive edge in an increasingly demanding global economy.
See full Telirite company page
